• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泌尿科药物的耳鼻喉不良反应。

Otorhinolaryngological adverse effects of urological drugs.

机构信息

Programa de Pós-Graduação em Medicina, Otorrinolaringologia da Universidade Federal de São Paulo - Escola Paulista de Medicina - UNIFESP, São Paulo, SP, Brasil.

Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço da Universidade Federal de São Paulo - Escola Paulista de Medicina - UNIFESP, São Paulo, SP, Brasil.

出版信息

Int Braz J Urol. 2021 Jul-Aug;47(4):747-752. doi: 10.1590/S1677-5538.IBJU.2021.99.06.

DOI:10.1590/S1677-5538.IBJU.2021.99.06
PMID:33566468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8321485/
Abstract

PURPOSE

To describe the otorhinolaryngological adverse effects of the main drugs used in urological practice.

MATERIALS AND METHODS

A review of the scientific literature was performed using a combination of specific descriptors (side effect, adverse effect, scopolamine, sildenafil, tadalafil, vardenafil, oxybutynin, tolterodine, spironolactone, furosemide, hydrochlorothiazide, doxazosin, alfuzosin, terazosin, prazosin, tamsulosin, desmopressin) contained in publications until April 2020. Manuscripts written in English, Portuguese, and Spanish were manually selected from the title and abstract. The main drugs used in Urology were divided into five groups to describe their possible adverse effects: alpha-blockers, anticholinergics, diuretics, hormones, and phosphodiesterase inhibitors.

RESULTS

The main drugs used in Urology may cause several otorhinolaryngological adverse effects. Dizziness was most common, but dry mouth, rhinitis, nasal congestion, epistaxis, hearing loss, tinnitus, and rhinorrhea were also reported and varies among drug classes.

CONCLUSIONS

Most of the drugs used in urological practice have otorhinolaryngological adverse effects. Dizziness was most common, but dry mouth, rhinitis, nasal congestion, epistaxis, hearing loss, tinnitus, and rhinorrhea were also reported. Therefore, doctors must be aware of these adverse effects to improve adherence to the treatment and to minimize damage to the health of patients.

摘要

目的

描述泌尿科常用药物的耳鼻喉不良影响。

材料与方法

使用特定描述符(副作用、不良反应、东莨菪碱、西地那非、他达拉非、伐地那非、奥昔布宁、托特罗定、螺内酯、呋塞米、氢氯噻嗪、多沙唑嗪、阿夫唑嗪、特拉唑嗪、哌唑嗪、坦索罗辛、去氨加压素)对科学文献进行了综述,检索时间截至 2020 年 4 月。从标题和摘要中手动选择英语、葡萄牙语和西班牙语撰写的手稿。将泌尿科常用药物分为 5 组,描述其可能产生的不良反应:α-受体阻滞剂、抗胆碱能药物、利尿剂、激素和磷酸二酯酶抑制剂。

结果

泌尿科常用药物可能引起多种耳鼻喉不良影响。最常见的是头晕,但也有报道称口干、鼻炎、鼻塞、鼻出血、听力损失、耳鸣和鼻漏,不同药物类别之间存在差异。

结论

泌尿科常用药物多数具有耳鼻喉不良影响。最常见的是头晕,但也有口干、鼻炎、鼻塞、鼻出血、听力损失、耳鸣和鼻漏等不良反应。因此,医生必须意识到这些不良反应,以提高治疗依从性,尽量减少对患者健康的损害。

相似文献

1
Otorhinolaryngological adverse effects of urological drugs.泌尿科药物的耳鼻喉不良反应。
Int Braz J Urol. 2021 Jul-Aug;47(4):747-752. doi: 10.1590/S1677-5538.IBJU.2021.99.06.
2
A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.α1肾上腺素能受体拮抗剂治疗提示良性前列腺梗阻的下尿路症状患者的疗效和耐受性的荟萃分析。
Eur Urol. 1999;36(1):1-13. doi: 10.1159/000019919.
3
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men.磷酸二酯酶5抑制剂他达拉非与两种α受体阻滞剂多沙唑嗪和坦索罗辛在健康血压正常男性中的相互作用。
J Urol. 2004 Nov;172(5 Pt 1):1935-40. doi: 10.1097/01.ju.0000142687.75577.e4.
4
Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia.坦索罗辛、多沙唑嗪和特拉唑嗪治疗良性前列腺增生的成本效益
J Manag Care Pharm. 2004 Sep-Oct;10(5):412-22. doi: 10.18553/jmcp.2004.10.5.412.
5
Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones.他达拉非与α受体阻滞剂(阿夫唑嗪、多沙唑嗪、坦索罗辛和西洛多辛)作为<10毫米远端和近端输尿管结石的药物排石疗法。
Arch Ital Urol Androl. 2018 Jun 30;90(2):117-122. doi: 10.4081/aiua.2018.2.117.
6
[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?].[用于症状性良性前列腺增生的α受体阻滞剂——所有药物都一样吗?]
Harefuah. 2008 Jun;147(6):514-9, 574.
7
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease.α-1 阻滞剂对糖酵解的影响与帕金森病发病风险的关系。
JAMA Neurol. 2021 Apr 1;78(4):407-413. doi: 10.1001/jamaneurol.2020.5157.
8
The role of combination medical therapy in benign prostatic hyperplasia.联合药物治疗在良性前列腺增生中的作用。
Int J Impot Res. 2008 Dec;20 Suppl 3:S33-43. doi: 10.1038/ijir.2008.51.
9
Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate.治疗良性前列腺增生的药物:在克隆的α1-肾上腺素能受体亚型及人前列腺中的亲和力比较
J Auton Pharmacol. 1996 Feb;16(1):21-8. doi: 10.1111/j.1474-8673.1996.tb00352.x.
10
Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease.α1-肾上腺素能受体(α1-AR)拮抗剂对前列腺细胞增殖和凋亡的影响:对前列腺疾病的治疗意义。
Prostate Suppl. 2000;9:42-6. doi: 10.1002/1097-0045(2000)45:9+<42::aid-pros9>3.0.co;2-u.

引用本文的文献

1
Desmopressin nasal spray inhibiting parasympathetic function on isolated tracheal smooth muscle.去氨加压素鼻喷剂抑制离体气管平滑肌的副交感神经功能。
Int J Med Sci. 2024 Jul 8;21(9):1783-1789. doi: 10.7150/ijms.98166. eCollection 2024.
2
Urethral reconstruction and genitoplasty highlighted in International Brazilian Journal of Urology.《巴西国际泌尿学杂志》重点介绍尿道重建与生殖器成形术。
Int Braz J Urol. 2021 Jul-Aug;47(4):699-701. doi: 10.1590/S1677-5538.IBJU.2021.04.01.

本文引用的文献

1
Perioperative Desmopressin for Patients Undergoing Otolaryngologic Procedures: A Systematic Review.围手术期去氨加压素在耳鼻喉科手术患者中的应用:系统评价。
Otolaryngol Head Neck Surg. 2019 Jul;161(1):36-45. doi: 10.1177/0194599819831288. Epub 2019 Mar 12.
2
Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder.抗毒蕈碱药物治疗膀胱过度活动症的基础和临床方面。
Pharmacol Ther. 2018 Sep;189:130-148. doi: 10.1016/j.pharmthera.2018.04.010. Epub 2018 Apr 27.
3
Management of Sea Sickness in Susceptible Flight Crews.易患晕船的飞行机组人员的晕船管理。
Mil Med. 2017 Nov;182(11):e1846-e1850. doi: 10.7205/MILMED-D-17-00029.
4
Vestibular Function Change in a Vasopressin-Induced Hydrops Model.血管加压素诱导的积水模型中的前庭功能变化
Otol Neurotol. 2017 Dec;38(10):e495-e500. doi: 10.1097/MAO.0000000000001574.
5
Alfuzosin: a clinically uroselective α-blocker.阿夫唑嗪:一种临床应用的尿路选择性α受体阻滞剂。
World J Urol. 2002 Apr;19(6):405-412. doi: 10.1007/s00345-002-0244-9.
6
Spironolactone.螺内酯
J Pain Symptom Manage. 2017 Feb;53(2):288-292. doi: 10.1016/j.jpainsymman.2016.12.320. Epub 2016 Dec 23.
7
The analgesic action of desmopressin in renal colic.去氨加压素在肾绞痛中的镇痛作用。
Acta Clin Belg. 2017 Jun;72(3):179-185. doi: 10.1080/17843286.2016.1230569. Epub 2016 Sep 23.
8
An update on the use of transdermal oxybutynin in the management of overactive bladder disorder.经皮奥昔布宁用于膀胱过度活动症管理的最新进展。
Ther Adv Urol. 2016 Apr;8(2):83-90. doi: 10.1177/1756287215626312. Epub 2016 Jan 19.
9
Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian women.奥昔布宁和托特罗定用于伊朗女性膀胱过度活动症治疗的一项试验
J Family Reprod Health. 2014 Jun;8(2):73-6.
10
The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.肾脏和肾外血管加压素 V2 受体的生理和病理生理功能。
Am J Physiol Renal Physiol. 2014 May 1;306(9):F931-40. doi: 10.1152/ajprenal.00604.2013. Epub 2014 Mar 5.